HomeTNXP • NASDAQ
add
Tonix Pharmaceuticals Holding Corp
Previous close
$15.08
Day range
$15.18 - $16.18
Year range
$6.76 - $130.00
Market cap
188.07M USD
Avg Volume
773.39K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 3.29M | 16.58% |
Operating expense | 34.99M | 108.01% |
Net income | -32.01M | -125.22% |
Net profit margin | -972.95 | -93.18% |
Earnings per share | -3.70 | 85.53% |
EBITDA | -32.61M | -116.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 190.06M | 573.17% |
Total assets | 252.44M | 165.76% |
Total liabilities | 21.30M | 2.50% |
Total equity | 231.14M | — |
Shares outstanding | 11.78M | — |
Price to book | 0.66 | — |
Return on assets | -37.59% | — |
Return on capital | -41.33% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -32.01M | -125.22% |
Cash from operations | -28.78M | -53.09% |
Cash from investing | -962.00K | -10,588.89% |
Cash from financing | 94.86M | 121.10% |
Net change in cash | 65.11M | 170.43% |
Free cash flow | -17.17M | -5.76% |
About
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
Founded
2007
Headquarters
Website
Employees
81
